Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 4, 2025
SEALSQ Unaffected by New Tariffs: Semiconductor Exemption Ensures Continuity, Bolstered by Company’s Innovation, U.S. Development Roadmap, and Post-Quantum Compliance
GlobeNewswire
·
April 4, 2025
Geneva, Switzerland, April 04, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today confirmed …
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and …
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today …
FOREWARN to Provide Identity Verification Services to Little Rock REALTORS® Association to Promote Agent Safety
GlobeNewswire
·
April 4, 2025
BOCA RATON, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Little Rock REALTORS® Association (“LRRA”) will …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
DALLAS, April 04, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …
A-Mark Precious Metals Announces Quarterly Cash Dividend and the Closing of Its Acquisition of AMS Holding, LLC
GlobeNewswire
·
April 4, 2025
EL SEGUNDO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 …
Tabhi acquires Mondee out of Chapter 11 Restructuring and Boosts Liquidity and Capital Structure
GlobeNewswire
·
April 4, 2025
AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) -- Mondee Holdings, Inc. announces its acquisition by Tabhi, and exit from Chapter 11 restructuring. Tabhi acquired substantially all the assets of Mondee Holdings, Inc. and strengthened its balance sheet by …
Genius Group files RICO lawsuit against Michael Moe and Peter Ritz, seeks over $450 million in damages
GlobeNewswire
·
April 4, 2025
SINGAPORE, April 04, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has filed a lawsuit against Peter Ritz and Michael Moe …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
Labrador Gold Provides Corporate Update
GlobeNewswire
·
April 4, 2025
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to provide an update on the Company’s strategic progress, including its ongoing efforts to secure a significant …
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
GlobeNewswire
·
April 4, 2025
– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees restricted stock units (RSUs) …
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
GlobeNewswire
·
April 4, 2025
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature …
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 4, 2025
BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it …
Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting
GlobeNewswire
·
April 4, 2025
Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation Presentation featuring network meta-analysis of SYMBRAVO® versus oral CGRPs NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- …
SCROOGE Casino Breaks Ground on First Orphanage: A Bold Step Beyond the Game
GlobeNewswire
·
April 4, 2025
Alexandria, Indiana, April 04, 2025 (GLOBE NEWSWIRE) -- In an era when most online casinos chase growth solely for profit, SCROOGE Casino is rewriting the rulebook — proving that entertainment can coexist with a higher purpose. Today, SCROOGE proudly …
Fire Alarm System Market Size Worth $58.79 Billion by 2031, at 7.4% CAGR, Globally | Exclusive Report by The Insight Partners
GlobeNewswire
·
April 4, 2025
US …
Infectious Disease Diagnostics Market Size to Reach USD 59.95 Million by 2030, Driven by Technological Advancements and Rising Disease Prevalence - The Insight Partners
GlobeNewswire
·
April 4, 2025
US …
Molecular Diagnostic for Infectious Diseases Market Size to Reach $17.61 Billion by 2030, Driven by Technological Advancements and Rising Global Disease Burden - The Insight Partners
GlobeNewswire
·
April 4, 2025
US …